U.S. markets open in 2 hours 46 minutes

vTv Therapeutics Inc. (VTVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9700+0.0100 (+0.51%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
163.24M227.48M143.49M127.88M159.83M
Enterprise Value 3
155.59M222.65M144.90M126.93M164.77M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
13.3620.723.71k3.07k43.08
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
21.05225.5822.6418.13kN/A
Enterprise Value/EBITDA 7
-14.21-37.7185.43-63.62-34.71

Trading Information

Stock Price History

Beta (5Y Monthly) -1.83
52-Week Change 3-30.74%
S&P500 52-Week Change 335.72%
52 Week High 34.7500
52 Week Low 31.4400
50-Day Moving Average 32.2715
200-Day Moving Average 32.4602

Share Statistics

Avg Vol (3 month) 31.58M
Avg Vol (10 day) 3576.25k
Shares Outstanding 560.19M
Implied Shares Outstanding 683.29M
Float 22.52M
% Held by Insiders 160.97%
% Held by Institutions 17.96%
Shares Short (Jul 14, 2021) 42.05M
Short Ratio (Jul 14, 2021) 41.01
Short % of Float (Jul 14, 2021) 48.69%
Short % of Shares Outstanding (Jul 14, 2021) 42.46%
Shares Short (prior month Jun 14, 2021) 42.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -108.43%
Operating Margin (ttm)-128.31%

Management Effectiveness

Return on Assets (ttm)-49.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.39M
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)12,237.50%
Gross Profit (ttm)-4.6M
EBITDA -9.4M
Net Income Avi to Common (ttm)-8.02M
Diluted EPS (ttm)-0.1590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.51M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)795k
Total Debt/Equity (mrq)12.48
Current Ratio (mrq)1.79
Book Value Per Share (mrq)-0.98

Cash Flow Statement

Operating Cash Flow (ttm)-17.74M
Levered Free Cash Flow (ttm)-4.81M